Cargando…
Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systematic review and meta-analysis
BACKGROUND: Gestational diabetes (GD) is associated with an increase in maternal and fetal morbidity. The risk factors involved have been clearly identified but no prevention strategies have yet provided robust evidence of their efficacy. Myoinositol has insulin sensitization properties and is of po...
Autores principales: | Bertrand, Anthéa, Gallot, Denis, Pereira, Bruno, Delabaere, Amélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772804/ https://www.ncbi.nlm.nih.gov/pubmed/36573918 http://dx.doi.org/10.1016/j.crphar.2022.100140 |
Ejemplares similares
-
Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
por: Sobota-Grzeszyk, Angelika, et al.
Publicado: (2019) -
Effectiveness and acceptability of myoinositol in prevention of gestational diabetes mellitus: A protocol for systematic review and meta-analysis
por: Wang, Li, et al.
Publicado: (2021) -
Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Greff, Dorina, et al.
Publicado: (2023) -
Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes
por: Guarnotta, Valentina, et al.
Publicado: (2022) -
Risk Factors for Perineal Wound Breakdown in Early Postpartum: A Retrospective Case–Control Study
por: Puissegur, Amandine, et al.
Publicado: (2023)